2i66: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2i66.gif|left|200px]]
{{Seed}}
[[Image:2i66.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2i66|  PDB=2i66  |  SCENE=  }}  
{{STRUCTURE_2i66|  PDB=2i66  |  SCENE=  }}  


'''Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis'''
===Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis===




==Overview==
<!--
The enzymatic cleavage of the nicotinamide-glycosidic bond on nicotinamide adenine dinucleotide (NAD(+)) has been proposed to go through an oxocarbenium ion-like transition state. Because of the instability of the ionic intermediate, there has been no structural report on such a transient reactive species. Human CD38 is an ectoenzyme that can use NAD(+) to synthesize two calcium-mobilizing molecules. By using NAD(+) and a surrogate substrate, NGD(+), we captured and determined crystal structures of the enzyme complexed with an intermediate, a substrate, and a product along the reaction pathway. Our results showed that the intermediate is stabilized by polar interactions with the catalytic residue Glu(226) rather than by a covalent linkage. The polar interactions between Glu(226) and the substrate 2',3'-OH groups are essential for initiating catalysis. Ser(193) was demonstrated to have a regulative role during catalysis and is likely to be involved in intermediate stabilization. In addition, a product inhibition effect by ADP-ribose (through the reorientation of the product) or GDP-ribose (through the formation of a covalently linked GDP-ribose dimer) was observed. These structural data provide insights into the understanding of multiple catalysis and clues for drug design.
The line below this paragraph, {{ABSTRACT_PUBMED_16951430}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 16951430 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_16951430}}


==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Reaction product]]
[[Category: Reaction product]]
[[Category: The catalytic pocket]]
[[Category: The catalytic pocket]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 07:07:22 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 05:20:57 2008''